CN104496929B - 一种含氯仿结晶的手性锌配合物晶体及用途 - Google Patents

一种含氯仿结晶的手性锌配合物晶体及用途 Download PDF

Info

Publication number
CN104496929B
CN104496929B CN201410824655.0A CN201410824655A CN104496929B CN 104496929 B CN104496929 B CN 104496929B CN 201410824655 A CN201410824655 A CN 201410824655A CN 104496929 B CN104496929 B CN 104496929B
Authority
CN
China
Prior art keywords
reaction
coordination compound
chloroform
column chromatography
zinc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201410824655.0A
Other languages
English (en)
Other versions
CN104496929A (zh
Inventor
罗梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201410824655.0A priority Critical patent/CN104496929B/zh
Publication of CN104496929A publication Critical patent/CN104496929A/zh
Application granted granted Critical
Publication of CN104496929B publication Critical patent/CN104496929B/zh
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2204Organic complexes the ligands containing oxygen or sulfur as complexing atoms
    • B01J31/2208Oxygen, e.g. acetylacetonates
    • B01J31/2226Anionic ligands, i.e. the overall ligand carries at least one formal negative charge
    • B01J31/2243At least one oxygen and one nitrogen atom present as complexing atoms in an at least bidentate or bridging ligand
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06Preparation of nitro compounds
    • C07C201/12Preparation of nitro compounds by reactions not involving the formation of nitro groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/30Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
    • B01J2231/34Other additions, e.g. Monsanto-type carbonylations, addition to 1,2-C=X or 1,2-C-X triplebonds, additions to 1,4-C=C-C=X or 1,4-C=-C-X triple bonds with X, e.g. O, S, NH/N
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/40Substitution reactions at carbon centres, e.g. C-C or C-X, i.e. carbon-hetero atom, cross-coupling, C-H activation or ring-opening reactions
    • B01J2231/44Allylic alkylation, amination, alkoxylation or analogues
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0213Complexes without C-metal linkages
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/02Compositional aspects of complexes used, e.g. polynuclearity
    • B01J2531/0238Complexes comprising multidentate ligands, i.e. more than 2 ionic or coordinative bonds from the central metal to the ligand, the latter having at least two donor atoms, e.g. N, O, S, P
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2531/00Additional information regarding catalytic systems classified in B01J31/00
    • B01J2531/20Complexes comprising metals of Group II (IIA or IIB) as the central metal
    • B01J2531/26Zinc
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

一种手性锌氮配合物,其化学式如下: 该手性锌氮配合物(I)的合成方法,其特征在于:由四氰乙烯和D‑苯丙氨醇在47mol%催化剂无水ZnCl2 于氯苯溶剂中回流反应48小时分离、纯化,即反应结束后脱去氯苯,加水溶解后用氯仿萃取,萃取相脱溶后用柱层析纯化;将配合物(I)用石油醚及二氯甲烷(3:7)淋洗,柱层析分离,自然挥发得配合物固体,再加入三氯甲烷,乙醇及正己烷各20配制饱和溶液,自然挥发得含三氯甲烷结晶的晶体。该手性锌氮配合物在苯甲醛的腈硅化反应、烯丙基烷基化反应、Baylis‑Hillman反应及亨利反应中显示了一定的催化效果,其转化率分别为82%、51%、48%及65%。

Description

一种含氯仿结晶的手性锌配合物晶体及用途
一、技术领域
本发明涉及一种金属有机配位化合物(配合物)及其用途,特别涉及含氮的手性金属有机配合物及其制备方法,确切地说是一种手性D-型锌氮配合物及用途。
二、背景技术
随着有机化学的发展,金属有机化合物在有机合成中的应用愈来愈广,是现在有机化学中极为活跃的领域之一,已经广泛应用于有机合成反应中。20世纪60年代后期出现的使用手性配体与过渡金属络合物催化的不对称合成反应大大加速了手性药物的研究。化学催化不对称合成法的重要内容便是手性配体及含金属催化剂的设计,从而使反应具有高效和高对映选择性。通常不对称催化剂所用的配体是噁唑啉,近年来噁唑啉锌配合物被广泛合成并取得较好的催化效果;
参考文献:
1. Ir(I) complexes with oxazoline-thioether ligands: nucleophilicattack of pyridine on coordinated 1,5-cyclooctadiene and application ascatalysts in imine hydrogenation, Guiu, Ester; Claver, Carmen; Castillon,Sergio, Journal of Organometallic Chemistry, 689(11), 1911-1918。
Chiral bis(oxazoline) complexes. Synthesis, structure andapplications in catalytic phospho-transfer, Jiang, M.; Dalgarno, S.; Kilner,C. A.; Halcrow, M. A.; Kee, T. P. Polyhedron, 20(17), 2151-2162。
New Bis(oxazolinyl)phenyl-Ruthenium(II) Complexes and TheirCatalytic Activity for Enantioselective Hydrogenation and TransferHydrogenation of Ketones, Ito, Jun-ichi; Ujiie, Satoshi; Nishiyama, Hisao,Organometallics, 28(2),630-638.
4.Lewis Acid-Catalyzed Enantioselective Hydroxylation Reactions ofOxindoles and β-Keto Esters
Using DBFOX Ligand,Ishimaru, Takehisa; Shibata, Norio; Nagai, Jun;Nakamura, Shuichi; Toru, Takeshi;
Kanemasa, Shuji, Journal of the American Chemical Society128(51),6488-16489。
三、发明内容
本发明旨在提供一种Zn-N金属有机配合物以应用于催化领域,所要解决的技术问题遴选噁唑啉作为配体并合成手性锌氮配合物。
本发明所称的手性锌配合物是双-(4R-苯基-4,5-二氢化-2-噁唑啉基)-乙腈锌配合物由四氰乙烯制备的由以下化学式所示的配合物:
化学名称:双-(4R-苯基-4,5-二氢化-2-噁唑啉基)-乙腈锌配合物,简称配合物(I)。
本配合物(I)的合成方法包括反应、分离和纯化,其特征是由四氰乙烯和D-苯甘氨醇在无水无氧条件下和催化剂无水ZnCl2 (49%)时于氯苯溶剂中回流反应48小时离、纯化,即反应结束后脱去氯苯,加水溶解后用氯仿萃取,萃取相脱溶后用柱层析纯化;
本配合物(I)的合成方法是四氰乙烯与D-苯甘氨醇在氯苯溶剂中回流反应48小时。
将配合物(I)用石油醚及二氯甲烷(3:7)淋洗,柱层析分离,自然挥发得配合物固体,再加入三氯甲烷,乙醇及正己烷各20配制饱和溶液,自然挥发得含三氯甲烷结晶的晶体。
该配合物的反应机理可推测为四氰乙烯在空气中及氯化锌作用下,不稳定,分解成三腈基甲烷,与2分子的D-苯甘氨醇作用形成双噁唑啉再与氯化锌按照2:1配位,并脱去两分子盐酸。
四、附图说明
图1是配合物 (I) 的单晶衍射图。
五、具体实施方式
(一)手性配合物的制备
1、双-(4-苯基-4,5-二氢化-2-噁唑啉基)-乙腈锌配合物的制备
在100mL两口瓶中,无水无氧条件下,加入无水ZnCl2 0.52g (3.82mmol), 40mL氯苯, 四氰乙烯1.0g(7.81mmol), D-苯甘氨醇10.0 g, 将混合物在高温下回流48h,停止反应,减压以除去溶剂, ,将剩余物用水溶解,并用CHCl3(20mLx2)萃取,有机相用无水硫酸钠干燥,旋转除去溶剂,将粗产品用石油醚/ 二氯甲烷(3:7)柱层析,得白色固体,产率78 %;M.P.:>220°C; [a]5 D=-300.6º (c=0.28, CH2Cl2):元素分析(C41 H33 Cl3 N6 O4 Zn):计算值:C:58.24 %, H, 3.93 %, N, 9.94 %;测试值:C:58.52 %, H, 3.57 %, N, 9.83 %;
配合物晶体数据如下:
经验式 C41 H33 Cl3 N6 O4 Zn
分子量 845.45
温度 293(2) K
波长 0.71073 Å
晶系, 空间群 单斜晶系 P21 21 21
晶胞参数 a = 10.9537(6) Å α = 90 °
b = 18.9994(10) Å β = 90 °
c = 19.1521(5) Å γ = 90 °
体积 3985.8(4)Å^3
电荷密度 4,1.409 Mg/m^3
吸收 校正参数 0.866 mm^-1
单胞内的电子数目 1736
晶体大小 0.211 x 0.165x 0.123 mm
Theta 角的范围 1.510 to 25.997 °
HKL的指标收集范围 -13<=h<=13, -20<k<23 -23<l<=22
收集/独立衍射数据 24441/ 7841 [R(int) = 0.0565]
theta = 30.5的数据完整度 100.0 %
吸收校正的方法 多层扫描
最大最小的透过率 0.7457 and 0.6155
精修使用的方法 F^2 的矩阵最小二乘法
数据数目/使用限制的数目/参数数目 7841/84/541
精修使用的方法 0.985
衍射点的一致性因子 R1 = 0.0533,ωR2= 0.1307
可观察衍射的吻合因子 R1 = 0.0768, ωR2 = 0.1444
绝对构型参数 0.030(9)
差值傅里叶图上的最大峰顶和峰谷 0.511 and -0.398e.Å^-3
晶体典型的键长数据:
Zn(1)-N(2) 1.984(5)
Zn(1)-N(3) 1.995(5)
Zn(1)-N(1) 2.013(5)
Zn(1)-N(4) 2.022(5)
N(1)-C(3) 1.281(8)
N(1)-C(1) 1.488(7)
N(2)-C(5) 1.298(8)
N(2)-C(7) 1.500(8)
N(3)-C(23) 1.296(8)
N(3)-C(21) 1.476(7)
N(4)-C(25) 1.303(8)
N(4)-C(27) 1.482(8)
N(5)-C(20) 1.140(8)
O(1)-C(3) 1.346(7)
O(1)-C(2) 1.452(8)
O(2)-C(5) 1.348(7)
O(2)-C(6) 1.435(8)
O(3)-C(23) 1.355(8)
O(3)-C(22) 1.432(8)
O(4)-C(25) 1.348(7)
O(4)-C(26) 1.433(10)
Cl(1)-C(41) 1.919(18)
Cl(2)-C(41) 1.682(16)
Cl(3)-C(41) 1.889(17)
Cl(1')-C(41) 1.536(19)
Cl(2')-C(41) 1.726(16)
Cl(3')-C(41) 1.480(15)
Cl(3')-H(41') 1.7509
晶体典型的键角数据:
N(2)-Zn(1)-N(3) 115.62(19)
N(2)-Zn(1)-N(1) 93.22(19)
N(3)-Zn(1)-N(1) 122.93(19)
N(2)-Zn(1)-N(4) 134.0(2)
N(3)-Zn(1)-N(4) 92.9(2)
N(1)-Zn(1)-N(4) 100.7(2)
C(3)-N(1)-C(1) 107.7(5)
C(3)-N(1)-Zn(1) 123.9(4)
C(1)-N(1)-Zn(1) 128.2(4)
C(5)-N(2)-C(7) 107.2(5)
C(5)-N(2)-Zn(1) 123.0(4)
C(7)-N(2)-Zn(1) 128.4(4)
C(23)-N(3)-C(21) 108.1(5)
C(23)-N(3)-Zn(1) 120.3(4)
C(21)-N(3)-Zn(1) 131.5(4)
C(25)-N(4)-C(27) 107.9(5)
C(25)-N(4)-Zn(1) 118.4(4)
C(27)-N(4)-Zn(1) 132.0(4)
C(3)-O(1)-C(2) 105.6(5)
C(5)-O(2)-C(6) 105.5(5)
C(23)-O(3)-C(22) 107.4(5)
C(25)-O(4)-C(26) 107.0(6)
C(41)-Cl(3')-H(41') 36.1
N(1)-C(1)-C(14) 111.9(5)
N(1)-C(1)-C(2) 102.1(5)
C(14)-C(1)-C(2) 115.2(6)
N(1)-C(1)-H(1) 109.2
C(14)-C(1)-H(1) 109.2
C(2)-C(1)-H(1) 109.2
O(1)-C(2)-C(1) 105.0(5)
O(1)-C(2)-H(2A) 110.8
C(1)-C(2)-H(2A) 110.8
O(1)-C(2)-H(2B) 110.8
C(1)-C(2)-H(2B) 110.8
H(2A)-C(2)-H(2B) 108.8
N(1)-C(3)-O(1) 117.0(5)
N(1)-C(3)-C(4) 127.4(5)
O(1)-C(3)-C(4) 115.6(5)
C(20)-C(4)-C(5) 118.8(6)
C(20)-C(4)-C(3) 119.3(6)
C(5)-C(4)-C(3) 121.8(5)
N(2)-C(5)-O(2) 115.6(5)
N(2)-C(5)-C(4) 129.2(6)
O(2)-C(5)-C(4) 115.2(5)
O(2)-C(6)-C(7) 105.0(5)
O(2)-C(6)-H(6A) 110.7
C(7)-C(6)-H(6A) 110.7
O(2)-C(6)-H(6B) 110.7
C(7)-C(6)-H(6B) 110.7
H(6A)-C(6)-H(6B) 108.8
C(8)-C(7)-N(2) 115.3(5)
C(8)-C(7)-C(6) 115.3(5)
N(2)-C(7)-C(6) 99.7(5)
C(8)-C(7)-H(7) 108.7
N(2)-C(7)-H(7) 108.7
C(6)-C(7)-H(7) 108.7
C(9)-C(8)-C(13) 117.7(6)
C(9)-C(8)-C(7) 122.4(6)
C(13)-C(8)-C(7) 119.8(6)
C(10)-C(9)-C(8) 122.4(7)
C(10)-C(9)-H(9) 118.8
C(8)-C(9)-H(9) 118.8
C(9)-C(10)-C(11) 118.0(8)
C(9)-C(10)-H(10) 121.0
C(11)-C(10)-H(10) 121.0
C(12)-C(11)-C(10) 120.5(7)
C(12)-C(11)-H(11) 119.7
C(10)-C(11)-H(11) 119.7
C(13)-C(12)-C(11) 119.5(7)
C(13)-C(12)-H(12) 120.3
C(11)-C(12)-H(12) 120.3
C(12)-C(13)-C(8) 121.8(7)
C(12)-C(13)-H(13) 119.1
C(8)-C(13)-H(13) 119.1
C(15)-C(14)-C(19) 118.5(8)
C(15)-C(14)-C(1) 120.2(8)
C(19)-C(14)-C(1) 121.3(6)
C(14)-C(19)-C(18) 120.6(9)
C(14)-C(19)-H(19) 119.7
C(18)-C(19)-H(19) 119.7
C(17)-C(18)-C(19) 122.0(11)
C(17)-C(18)-H(18) 119.0
C(19)-C(18)-H(18) 119.0
C(18)-C(17)-C(16) 119.2(11)
C(18)-C(17)-H(17) 120.4
C(16)-C(17)-H(17) 120.4
C(17)-C(16)-C(15) 119.4(11)
C(17)-C(16)-H(16) 120.3
C(15)-C(16)-H(16) 120.3
C(14)-C(15)-C(16) 120.3(10)
C(14)-C(15)-H(15) 119.9
C(16)-C(15)-H(15) 119.9
N(5)-C(20)-C(4) 179.5(9)
N(3)-C(21)-C(34) 115.1(5)
N(3)-C(21)-C(22) 101.9(5)
C(34)-C(21)-C(22) 111.5(6)
N(3)-C(21)-H(21) 109.4
C(34)-C(21)-H(21) 109.4
C(22)-C(21)-H(21) 109.4
O(3)-C(22)-C(21) 103.8(5)
O(3)-C(22)-H(22A) 111.0
C(21)-C(22)-H(22A) 111.0
O(3)-C(22)-H(22B) 111.0
C(21)-C(22)-H(22B) 111.0
H(22A)-C(22)-H(22B) 109.0
N(3)-C(23)-O(3) 114.7(6)
N(3)-C(23)-C(24) 128.4(6)
O(3)-C(23)-C(24) 116.9(6)
C(23)-C(24)-C(25) 123.5(6)
C(23)-C(24)-C(40) 122.5(10)
C(25)-C(24)-C(40) 112.2(10)
C(23)-C(24)-C(40') 114.1(9)
C(25)-C(24)-C(40') 120.0(9)
N(4)-C(25)-O(4) 115.1(6)
N(4)-C(25)-C(24) 127.7(5)
O(4)-C(25)-C(24) 117.1(6)
O(4)-C(26)-C(27) 104.7(5)
O(4)-C(26)-H(26A) 110.8
C(27)-C(26)-H(26A) 110.8
O(4)-C(26)-H(26B) 110.8
C(27)-C(26)-H(26B) 110.8
H(26A)-C(26)-H(26B) 108.9
N(4)-C(27)-C(26) 102.0(6)
N(4)-C(27)-C(28) 112.5(5)
C(26)-C(27)-C(28) 110.5(5)
N(4)-C(27)-H(27) 110.5
C(26)-C(27)-H(27) 110.5
C(28)-C(27)-H(27) 110.5
C(33)-C(28)-C(29) 117.5(8)
C(33)-C(28)-C(27) 123.4(6)
C(29)-C(28)-C(27) 118.6(7)
C(28)-C(29)-C(30) 122.4(11)
C(28)-C(29)-H(29) 118.8
C(30)-C(29)-H(29) 118.8
C(29)-C(30)-C(31) 118.4(10)
C(29)-C(30)-H(30) 120.8
C(31)-C(30)-H(30) 120.8
C(32)-C(31)-C(30) 119.9(10)
C(32)-C(31)-H(31) 120.1
C(30)-C(31)-H(31) 120.1
C(31)-C(32)-C(33) 120.2(11)
C(31)-C(32)-H(32) 119.9
C(33)-C(32)-H(32) 119.9
C(28)-C(33)-C(32) 121.5(9)
C(28)-C(33)-H(33) 119.2
C(32)-C(33)-H(33) 119.2
C(35)-C(34)-C(39) 118.7(7)
C(35)-C(34)-C(21) 121.7(6)
C(39)-C(34)-C(21) 119.5(6)
C(34)-C(35)-C(36) 119.8(9)
C(34)-C(35)-H(35) 120.1
C(36)-C(35)-H(35) 120.1
C(37)-C(36)-C(35) 120.0(10)
C(37)-C(36)-H(36) 120.0
C(35)-C(36)-H(36) 120.0
C(38)-C(37)-C(36) 120.5(10)
C(38)-C(37)-H(37) 119.7
C(36)-C(37)-H(37) 119.7
C(37)-C(38)-C(39) 120.7(9)
C(37)-C(38)-H(38) 119.6
C(39)-C(38)-H(38) 119.6
C(38)-C(39)-C(34) 120.2(8)
C(38)-C(39)-H(39) 119.9
C(34)-C(39)-H(39) 119.9
N(6)-C(40)-C(24) 168(3)
N(6')-C(40')-C(24) 178(2)
Cl(3')-C(41)-Cl(1') 133.5(13)
Cl(3')-C(41)-Cl(2') 108.6(11)
Cl(1')-C(41)-Cl(2') 117.8(12)
Cl(2)-C(41)-Cl(3) 95.5(10)
Cl(2)-C(41)-Cl(1) 98.5(10)
Cl(3)-C(41)-Cl(1) 101.5(10)
Cl(2)-C(41)-H(41) 121.0
Cl(3)-C(41)-H(41) 120.9
Cl(1)-C(41)-H(41) 115.2
Cl(3')-C(41)-H(41') 86.3
Cl(1')-C(41)-H(41') 101.8
Cl(2')-C(41)-H(41') 79.9
(三)、腈硅化反应应用
2-苯基-2-(三甲硅氧基)丙腈
0.1mmol 配合物I, 苯甲醛0.1mL, TMSCN 0.3 ml (3.3mmol), 2mL二氯甲烷 相继在20~30˚C下加入,3天后, 加入水淬灭经柱层后(石油醚/二氯甲烷:5/1),得无色油状液体, 产率分别为:82%;1H NMR (300MHz, CDCl3) 7.56–7.59 (m, 0.9 Hz, 2H), 7.31–7.34 (m, 3H), 5.43 (s, 1H), 0.16 (s, 9H). 13C NMR (75 MHz, CDCl3) 136.1, 128.8(x2), 126.2(x2), 119.1, 63.5, -0.39(x3)。
(四)、烯丙基烷基化反应应用
取0.20mmol的配合物I(催化用量为20%)于25mL的小烧瓶中,加入2毫升的二氯甲烷溶液,然后,向上述溶液中加入0.1mL的苯甲醛与0.3mL的烯丙基三甲基硅烷,常温搅拌,反应小72小时后,进行核磁分析,转化率:51 %;1H NMR (300MHz, CDCl3) 7.27~7.33(m,5H, Ar-H), 5.79~5.80(m, 1H), 5.12~5.17 (m, 2H, -CH2), 4.71(d,J=5Hz,1H),2.49~2.50(m, 2H),2.28(s, 1H)。
(五)Baylis-Hillman反应应用
取0.20mmol的配合物I(催化用量为20%)于25mL的小烧瓶中,加入2毫升的二氯甲烷溶液,然后,向上述溶液中加入0.1mL的苯甲醛与0.5mL丙烯酸甲酯,常温搅拌,反应小72小时后,进行核磁分析,转化率:48 %; 1HNMR (300MHz, CDCl3) 7.20~7.41 (m, 5H, Ar-H), 6.30(s, 1H), 5.45 (s, 1H), 3.70(s, 3H), 3.15(s, 1H)。
(六)亨利反应应用
2-硝基-1苯基乙醇的制备
取0.20mmol的配合物I(催化用量为20%)于25mL的小烧瓶中,加入2毫升的无水甲醇溶液,然后,向上述溶液中加入0.1mL的苯甲醛与0.5mL的硝基甲烷,常温搅拌,反应小72小时后,进行核磁分析,转化率:65 %;1H NMR (300MHz, CDCl3) 7.28~7.32 (m, 5H, Ar-H), 5.32~5.35(d, J=9.18Hz, 1H, -CH), 4.38~4.56 (m, 2H, -CH2), 3.89(br, 1H,-OH)。

Claims (3)

1.一种由以下化学式(I)所示的手性锌氮配合物:
在293K±2K温度下,在牛津X-射线单晶衍射仪上,用经石墨单色器单色化的MoKα射线 以ω-θ扫描方式收集衍射数据,其特征在于晶体属单斜晶系,晶胞参数: α=90°;β=90°;γ=90°。
2.权利要求1所示的手性锌氮配合物的合成方法,其特征在于:由四氰乙烯和D-苯丙氨醇在49mol%催化剂无水ZnCl2于氯苯溶剂中回流反应48小时分离、纯化,即反应结束后脱去氯苯,加水溶解后用氯仿萃取,萃取相脱溶后用柱层析纯化;将配合物(I)用石油醚及二氯甲烷按体积比3:7淋洗,柱层析分离,自然挥发得配合物固体,再加入三氯甲烷,乙醇及正己烷各20配制饱和溶液,自然挥发得含三氯甲烷结晶的式(I)所示的晶体化合物。
3.权利要求1所示的手性锌氮配合物的应用,其在苯甲醛的腈硅化反应、烯丙基烷基化反应、Baylis-Hillman反应及亨利反应中转化率分别为82%、51%、48%及65%。
CN201410824655.0A 2014-12-27 2014-12-27 一种含氯仿结晶的手性锌配合物晶体及用途 Expired - Fee Related CN104496929B (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410824655.0A CN104496929B (zh) 2014-12-27 2014-12-27 一种含氯仿结晶的手性锌配合物晶体及用途

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410824655.0A CN104496929B (zh) 2014-12-27 2014-12-27 一种含氯仿结晶的手性锌配合物晶体及用途

Publications (2)

Publication Number Publication Date
CN104496929A CN104496929A (zh) 2015-04-08
CN104496929B true CN104496929B (zh) 2016-08-24

Family

ID=52938403

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410824655.0A Expired - Fee Related CN104496929B (zh) 2014-12-27 2014-12-27 一种含氯仿结晶的手性锌配合物晶体及用途

Country Status (1)

Country Link
CN (1) CN104496929B (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105218473B (zh) * 2015-10-18 2018-01-19 合肥祥晨化工有限公司 一种含甲醇结晶的手性锌配合物
CN105622646B (zh) * 2015-12-31 2017-05-31 合肥工业大学 一种锌配合物晶体
CN106977553A (zh) * 2017-04-30 2017-07-25 合肥祥晨化工有限公司 一种手性银配合物晶体的制备及合成方法

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120095180A1 (en) * 2010-10-15 2012-04-19 The Regents Of The University Of California Office Of Technology Transfer Isolation of a c5-deprotonated imidazolium, a crystalline abnormal n-heterocyclic carbene
CN102617499A (zh) * 2012-03-09 2012-08-01 罗梅 一种手性锌配合物
CN102627616A (zh) * 2012-03-21 2012-08-08 罗梅 一种手性锌配合物
CN102633738A (zh) * 2012-04-05 2012-08-15 罗梅 一种手性锌配合物
CN103232480A (zh) * 2013-01-25 2013-08-07 罗梅 一种手性锌配合物

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120095180A1 (en) * 2010-10-15 2012-04-19 The Regents Of The University Of California Office Of Technology Transfer Isolation of a c5-deprotonated imidazolium, a crystalline abnormal n-heterocyclic carbene
CN102617499A (zh) * 2012-03-09 2012-08-01 罗梅 一种手性锌配合物
CN102627616A (zh) * 2012-03-21 2012-08-08 罗梅 一种手性锌配合物
CN102633738A (zh) * 2012-04-05 2012-08-15 罗梅 一种手性锌配合物
CN103232480A (zh) * 2013-01-25 2013-08-07 罗梅 一种手性锌配合物

Also Published As

Publication number Publication date
CN104496929A (zh) 2015-04-08

Similar Documents

Publication Publication Date Title
CN102887912B (zh) 一种手性锌配合物
CN102807577B (zh) 一种手性化合物
CN104496929B (zh) 一种含氯仿结晶的手性锌配合物晶体及用途
CN104876970B (zh) 一种手性双噁唑啉钯配合物晶体及合成方法
Chen et al. Synthesis of Enantioenriched 1, 2‐cis Disubstituted Cycloalkanes by Convergent NiH Catalysis
CN102936204B (zh) 一种手性化合物
CN104628788A (zh) 一种手性噁唑啉钯配合物及用途
CN105218473B (zh) 一种含甲醇结晶的手性锌配合物
CN105001268A (zh) 一种手性噁唑啉铂配合物晶体及其合成方法
CN102850383B (zh) 一种手性锌配合物
CN105237413B (zh) 一种手性含结晶水苯甘氨醇钴配合物
CN103709204B (zh) 一种钴配合物、制备方法及其用途
CN102627616B (zh) 一种手性锌配合物
Zhang et al. Asymmetric synthesis of 1, 2-bis (diphenylphosphino)-1-phenylethane via a chiral palladium template promoted hydrophosphination reaction
CN108727290A (zh) 一种手性噁唑啉钯配合物及用途
CN103570765B (zh) 一种手性噁唑啉锰配合物晶体及其合成方法
CN103665038B (zh) 一种碳磷手性二烃基氧膦及其合成方法
CN103145742B (zh) 一种手性噁唑啉锌配合物
CN104327104A (zh) 一种同质异晶手性锌配合物
CN102617499B (zh) 一种手性锌配合物
CN102863464B (zh) 一种手性锌配合物
CN103724212B (zh) 一种手性(s)-苯乙胺盐酸盐氯化钴配合物晶体
CN110467527A (zh) 一种制备反式右旋菊酸的方法
CN103319542B (zh) 一种手性噁唑啉钴配合物及其合成方法
CN103012445B (zh) 一种手性锌配合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20160824

Termination date: 20211227

CF01 Termination of patent right due to non-payment of annual fee